Loading company details...
Latest Form 4 (Nov 13, 2026): Laura Brege (Director): Exercise/Conversion of 14,167 shares, $236.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Laura Brege | Exercise/Conversion | 14,167 | $236.7K |
| Nov 5, 2026 | Christopher Peetz, CHIEF EXECUTIVE OFFICER | Exercise/Conversion | 20,000 | $58.7K |
| Oct 19, 2026 | Jolanda Howe, SVP, GLOBAL CONTROLLER | Exercise/Conversion | 16,112 | $310.0K |
| Oct 14, 2026 | Robert Paul Myers, Chief Medical Officer | Grant/Award | 40,000 | n/a |
| Oct 7, 2026 | Christopher Peetz, CHIEF EXECUTIVE OFFICER | Exercise/Conversion | 5,305 | $101.8K |
| Sep 15, 2026 | Eric Bjerkholt, CHIEF FINANCIAL OFFICER | Exercise/Conversion | 18,333 | n/a |
| Sep 3, 2026 | Jolanda Howe, SVP, GLOBAL CONTROLLER | Sale | 658 | $65.8K |
| Sep 3, 2026 | Christopher Peetz, CHIEF EXECUTIVE OFFICER | Exercise/Conversion | 30,000 | $88.1K |
| Aug 19, 2026 | Jolanda Howe, SVP, GLOBAL CONTROLLER | Exercise/Conversion | 40,000 | $250.8K |
| Aug 12, 2026 | Eric Bjerkholt, CHIEF FINANCIAL OFFICER | Sale | 6,001 | $599.5K |